Trials / Withdrawn
WithdrawnNCT06070948
A Study to Assess Food Effect of Venetoclax New Tablet Formulation in Healthy Female Participants
A Bioavailability and Food Effect Study of Venetoclax New High Drug Load Tablet Formulation in Healthy Female Subjects
- Status
- Withdrawn
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- AbbVie · Industry
- Sex
- Female
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the bioavailability of two different doses of venetoclax new high drug load formulation tablets relative to two tablets of the currently marketed venetoclax tablets under fed conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Venetoclax | Oral; Tablet |
Timeline
- Start date
- 2023-10-05
- Primary completion
- 2025-07-28
- Completion
- 2025-07-28
- First posted
- 2023-10-06
- Last updated
- 2024-06-21
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06070948. Inclusion in this directory is not an endorsement.